Otero-Garcia Oscar, de la Fuente-Lopez Pablo, Cinza-Sanjurjo Sergio, Cordero Alberto, Mazón-Ramos Pilar, Rey-Aldana Daniel, Gómez-Otero Ines, Portela-Romero Manuel, Garcia-Vega David, González-Juanatey José Ramón
Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Choupana s/n, Santiago de Compostela, PC 15706, A Coruña, Spain; Centro de Investigación Biomédica en Red-Enfermedades Cardiovasculares (CIBERCV), Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0 28029, Madrid, Spain; Servicio de Cardiología, Complejo Hospitalario Universitario de Santiago de Compostela, PC 15706, Choupana s/n, Santiago de Compostela, A Coruña, Spain.
Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Choupana s/n, Santiago de Compostela, PC 15706, A Coruña, Spain; Centro de Investigación Biomédica en Red-Enfermedades Cardiovasculares (CIBERCV), Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0 28029, Madrid, Spain; Servicio de Cardiología, Complejo Hospitalario Universitario de Santiago de Compostela, PC 15706, Choupana s/n, Santiago de Compostela, A Coruña, Spain.
Int J Cardiol. 2025 Mar 1;422:132947. doi: 10.1016/j.ijcard.2024.132947. Epub 2024 Dec 30.
Over the last two decades, reductions in cardiovascular (CV) and cerebrovascular events for patients with atrial fibrillation (AF) have been observed, but the non-cardiovascular rates have increased. Early initiation of oral anticoagulation helps reduce AF complications; however, the impact of delayed cardiology care after referral by a Primary Care Physician (PCP) is unknown. The aim of our study is to investigate the association between the elapsed time to cardiology care following a PCP referral and one-year outcomes among patients with AF and analyses gender-specific differences in these outcomes.
All PCP referrals with previous AF diagnoses to cardiology consultation from 2010 to 2021 (N = 15,224) were analysed. The outcomes analysed were all-cause, CV, and stroke mortality and hospitalizations rates at one-year. Cox regression adjusted for age, sex, diabetes mellitus, hypertension, atrial fibrillation, peripheral arterial disease, and stroke analysed the risk associated with elapsed time. Odds ratios and 95 % confidence interval (OR [95 % CI]) were calculated.
Delay time from PCP referral to cardiology care was associated with an increase per day of delay in all-cause (0.25 %), CV (0.13 %), HF (0.11 %) and stroke (0.14 %) mortality rates. Multivariate analyses showed that elapsed time was associated with a higher risk of all-cause (1.005 [1.003-1.007]), CV-mortalities (1.006 [1.005-1.007]), all-cause (1.005 [1.003-1.006]), and CV-hospitalizations (1.009 [1.006-1.012]). Gender-specific analyses revealed that men had higher all-cause mortality (5.3 % vs. 4.0 %, p < 0.001), while women exhibited higher stroke mortality (2.7 % vs. 1.5 %, p = 0.005) and haemorrhagic mortality (4.7 % vs. 3.2 %, p = 0.012). AF complications also increased with the delay time: stroke (1007 [1001-1013]), and cerebral haemorrhage (1008 [1005-1011]).
Elapsed time for cardiology care was associated with an increase in AF complications (stroke and haemorrhage), all-cause, CV-related mortality and hospitalizations rates at one-year. Gender differences were evident, with women demonstrating higher stroke and haemorrhagic mortality rates despite similar delays in care. These findings underscore the need for gender-tailored risk stratification and timely cardiology care to optimise outcomes.
在过去二十年中,已观察到心房颤动(AF)患者的心血管(CV)和脑血管事件有所减少,但非心血管疾病发生率却有所上升。早期开始口服抗凝有助于降低房颤并发症;然而,初级保健医生(PCP)转诊后延迟心脏科治疗的影响尚不清楚。我们研究的目的是调查PCP转诊后至心脏科治疗的时间间隔与房颤患者一年结局之间的关联,并分析这些结局中的性别差异。
分析了2010年至2021年期间所有被PCP转诊至心脏科会诊且既往有房颤诊断的患者(N = 15224)。分析的结局指标为一年时的全因死亡率、CV死亡率、卒中死亡率以及住院率。Cox回归模型对年龄、性别、糖尿病、高血压、房颤、外周动脉疾病和卒中进行了校正,分析了与时间间隔相关的风险。计算了比值比和95%置信区间(OR [95% CI])。
从PCP转诊至心脏科治疗的延迟时间与全因死亡率(0.25%)、CV死亡率(0.13%)、心力衰竭(HF,0.11%)和卒中死亡率(0.14%)每日的增加相关。多变量分析显示,时间间隔与全因死亡风险更高(1.005 [1.003 - 1.007])、CV死亡风险更高(1.006 [1.005 - 1.007])、全因住院风险更高(1.005 [1.003 - 1.006])以及CV住院风险更高(1.009 [1.006 - 1.012])相关。性别特异性分析显示,男性的全因死亡率更高(5.3% 对 4.0%,p < 0.001),而女性的卒中死亡率更高(2.7% 对 1.5%,p = 0.005)以及出血性死亡率更高(4.7% 对 3.2%,p = 0.012)。房颤并发症也随着延迟时间增加:卒中(1007 [1001 - 1013])和脑出血(1008 [1005 - 1011])。
心脏科治疗的时间间隔与房颤并发症(卒中和出血)增加、全因死亡率、CV相关死亡率以及一年时的住院率相关。性别差异明显,尽管治疗延迟相似,但女性的卒中死亡率和出血性死亡率更高。这些发现强调了需要进行针对性别的风险分层以及及时的心脏科治疗以优化结局。